| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 |
| I811869 | MACKLIN | 异哌啶酸 | 98% | 30元/25g; 49元/100g; 228元/500g; 1122元/2.5kg; | 展开 |
储存:2~8°C,干燥,密封 状态:白色到浅棕褐色粉末或块状 |
| I794639 | MACKLIN | 异哌啶酸 | 10mM in Water | 186元/1ml; | 展开 |
|
| I0256 | TCI | 4-Piperidinecarboxylic Acid | >98.0%(T) | 150元/25G; 490元/100G; 1490元/500G; | 展开 |
基本信息 | 纯度/分析方法 | >98.0%(T) | | 分子式/分子量 | C6H11NO2 = 129.16 | | 外观与形状(20℃) | 固体 | | Reaxys-RN | 112553 | | PubChem物质ID | 87571621 | | SDBS (AIST Spectral DB) | 4646 | | Merck Index (14) | 5189 | | MDL编号 | MFCD00006004 |
技术规格 | Appearance | White to Light yellow to Light red powder to crystal | | Purity(Nonaqueous Titration) | min. 98.0 % | | Solubility in Water | very faint turbidity |
物性(参考值) 安全信息 | 图形或危害标志 |  | | 信号词 | 警告 | | 危险性说明 | H315 : 造成皮肤刺激。 H319 : 造成严重眼刺激。
| | 防范说明 | P264 : 作业后彻底清洗皮肤。 P280 : 戴防护手套/戴防护眼罩/戴防护面具。 P302 + P352 : 如皮肤沾染:用水充分清洗。 P337 + P313 : 如仍觉眼刺激:求医/就诊。 P305 + P351 + P338 : 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P362+P364 : 脱掉沾污的衣服,清洗后方可重新使用。 P332 + P313 : 如发生皮肤刺激:求医/就诊。
|
相关法规 |
| 284826 | J&K | 4-Piperidinecarboxylic Acid | 98% | 60元/5G; 142元/25G; 440元/100G; | 展开 |
基本信息 | 分子式 | C6H11NO2 | | 分子量 | 129.16 | | 熔点 | 336 | | MDL编码 | MFCD00006004 | | Beilstein | 112553 | | Merck | 14,5189 | | EINECS 编号 | 207-872-3 |
安全信息 | 图形或危害标志 |  | | 提示语 | Warning | | 危险说明 | H315 H319 H335 | | 防范说明 | P261 P305+P351+P338 | | WGK | 3 | | RTECS | NS5150000 | | TSCA | 是 |
|
| A11795 | Alfa Aesar | Isonipecotic Acid | 98% | 1376元/25g; 3789元/100g; | 展开 |
应用 A GABA-A receptor partial agonist 基本信息 MDL MFCD00006004 EINECS 207-872-3 分子式 C6H11NO2 分子量 129.16 熔点 >350° 灵敏度 Ambient temperatures. 形态 Powder Beilstein 112553 Merck 14,5189 安全信息 RTECS NS5150000 TSCA 是 |
| I18008 | Sigma-Aldrich | Isonipecotic Acid | 97% | 308.6元/25 G; 728.31元/100 G; | 展开 |
产品说明 应用 用于合成以下物质的反应物: - 用于组织蛋白酶 B 抑制的抗生素硝酰基衍生物
- 1-磷酸鞘氨醇受体激动剂
- 心血管疾病治疗的 RhoA 抑制剂
- 烷基哌啶和哌嗪异羟肟酸作为 HDAC 抑制剂
- CHK1 抑制剂
- 用于类风湿性关节炎治疗研究的 IKK2 抑制剂
包装 25, 100 g in poly bottle 基本信息 | 经验(实验)分子式 | C6H11NO2 | | 分子量 | 129.16 | | Beilstein | 112553 | | EC 号 | 207-872-3 | | MDL编号 | MFCD00006004 | | PubChem化学物质编号 | 24278166 | | NACRES | NA.22 |
产品性质 | 质量水平 | 200 | | 测定 | 97% | | mp | >300 ℃ (lit.) | | SMILES string | OC(=O)C1CCNCC1 | | InChI | 1S/C6H11NO2/c8-6(9)5-1-3-7-4-2-5/h5,7H,1-4H2,(H,8,9) | | InChI key | SRJOCJYGOFTFLH-UHFFFAOYSA-N |
安全信息 | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | dust mask type N95 (US), Eyeshields, Gloves |
|
| 009837 | Fluorochem | Piperidine-4-carboxylic acid | 98% | 220元/25g; 528元/100g; 1034元/250g; | 展开 |
基本信息 | CAS Number | 498-94-2 | | MDL Number | MFCD00006004 | | Melting Point | 300℃ |
安全信息 | 图形或危害标志 |  | | 危险性说明 | H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation.
| | 防范说明 | P233: Keep container tightly closed. P260: Do not breathe . P261: Avoid breathing . P264: Wash hands thoroughly after handling. P271: Use only outdoors or in a well-ventilated area. P280: Wear . P302 + P352: IF ON SKIN: Wash with plenty of soap and water. P304: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.. P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312: Call a POISON CENTER or doctor/physician if you feel unwell. P321: Specific treatment (see relevant procedures. on this label). P332 + P313: If skin irritation occurs: Get medical advice/ attention. P337 + P313: If eye irritation persists: Get medical advice/attention. P340: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P362: Take off contaminated clothing and wash before reuse. P403: Store in a well-ventilated place. P403 + P233: Store in a well-ventilated place. Keep container tightly closed. P405: Store locked up. P501: Dispose of contents/container to in accordance with local regulation .
|
|